Literature DB >> 11707162

Opioid antagonists in the treatment of alcohol dependence.

G O'Leary1, J Borrow, R D Weiss.   

Abstract

This article reviews the use of opioid antagonists in the pharmacologic treatment of alcohol dependence. The rationale for using the opioid antagonists naltrexone and nalmefene to prevent relapse in alcohol-dependent subjects is discussed by reviewing past and current clinical trials. The role of psychotherapies, particularly coping skills therapy, in combination with opioid antagonists is highlighted in the presentations of the clinical data. Finally, future research directions for opioid antagonists are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11707162     DOI: 10.1007/s11920-001-0042-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   8.081


  40 in total

1.  A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.

Authors:  J Chick; R Anton; K Checinski; R Croop; D C Drummond; R Farmer; D Labriola; J Marshall; J Moncrieff; M Y Morgan; T Peters; B Ritson
Journal:  Alcohol Alcohol       Date:  2000 Nov-Dec       Impact factor: 2.826

2.  Naltrexone pharmacology, pharmacokinetics, and metabolism: current status.

Authors:  K Verebey; S J Mulé
Journal:  Am J Drug Alcohol Abuse       Date:  1975       Impact factor: 3.829

3.  Targeted naltrexone treatment of early problem drinkers.

Authors:  H R Kranzler; H Tennen; C Penta; M J Bohn
Journal:  Addict Behav       Date:  1997 May-Jun       Impact factor: 3.913

4.  Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.

Authors:  W R Martin; D R Jasinski; P A Mansky
Journal:  Arch Gen Psychiatry       Date:  1973-06

5.  A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.

Authors:  B J Mason; F R Salvato; L D Williams; E C Ritvo; R B Cutler
Journal:  Arch Gen Psychiatry       Date:  1999-08

6.  Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.

Authors:  M E McCaul; G S Wand; C Rohde; S M Lee
Journal:  Alcohol Clin Exp Res       Date:  2000-09       Impact factor: 3.455

7.  High-dose naltrexone therapy and dietary counseling for obesity.

Authors:  J E Mitchell; J E Morley; A S Levine; D Hatsukami; M Gannon; D Pfohl
Journal:  Biol Psychiatry       Date:  1987-01       Impact factor: 13.382

8.  Alcohol interactions with brain opiate receptors.

Authors:  B Tabakoff; P L Hoffman
Journal:  Life Sci       Date:  1983-01-17       Impact factor: 5.037

9.  Naltrexone-induced alterations in human ethanol intoxication.

Authors:  R M Swift; W Whelihan; O Kuznetsov; G Buongiorno; H Hsuing
Journal:  Am J Psychiatry       Date:  1994-10       Impact factor: 18.112

10.  Tests of opioid deficiency hypotheses of alcoholism.

Authors:  L D Reid; J D Delconte; M L Nichols; E J Bilsky; C L Hubbell
Journal:  Alcohol       Date:  1991 Jul-Aug       Impact factor: 2.405

View more
  1 in total

Review 1.  Bidirectional translational research: Progress in understanding addictive diseases.

Authors:  M J Kreek; S D Schlussman; B Reed; Y Zhang; D A Nielsen; O Levran; Y Zhou; E R Butelman
Journal:  Neuropharmacology       Date:  2008-08-07       Impact factor: 5.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.